Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …


Install CouponFollow Chrome Extension   CouponFollow Extension

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

a9oncology.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals PR Newswire Wed, Oct 23, …

yahoo.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024  · In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology announced an oversubscribed $175 million series C financing to support advancement of its …

insideprecisionmedicine.com

$175
OFF

Radiopharmaceuticals | Cancer Therapy | News - Alpha-9 Oncology

4 weeks from now

Jan 8, 2024  · Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals. ... October 15, 2024. Alpha-9 …

a9oncology.com

$175
OFF

Alpha-9 Oncology Secures $175 Million In Oversubscribed Series C …

4 weeks from now

Oct 24, 2024  · Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an …

readmagazine.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

biospace.com

$175
OFF

Alpha-9 Oncology Raises $175 Million In Series C | Citybiz

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology Inc., a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an …

citybiz.co

$175
OFF

Alpha-9 Oncology Secures $175M Series C To Drive …

4 weeks from now

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to advance its radiopharmaceutical pipeline for cancer …

jacobsmgt.com

$175
OFF

Alpha-9 Oncology Raises $175M In Series C Financing

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology Inc., a Boston, MA- and Vancouver, Canada-based clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of …

finsmes.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals October 23 2024 - 8:00AM PR Newswire (US)

advfn.com

$175
OFF

Alpha-9 Oncology | Radiopharmaceuticals | Cancer Therapy

4 weeks from now

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals. BOSTON, Mass. and VANCOUVER, British …

a9oncology.com

$175
OFF

Alpha-9 Oncology Secures $175M In Oversubscribed Series C …

4 weeks from now

Nov 1, 2024  · Alpha-9 Oncology Inc., a clinical stage company focused on developing radiopharmaceuticals to enhance cancer treatment, has announced the successful closing of …

patsnap.com

$175
OFF

Alpha-9 Oncology Raises $175 Million In Funding

4 weeks from now

Oct 24, 2024  · 9 Oncology has raised $175 million in a Series C funding round. The new round was led by Lightspeed Venture Partners and Ascenta Capital. A selected syndicate of new …

substack.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, October 23, 2024-- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

vcaonline.com

$175
OFF

Radiopharma Biotech Alpha-9 Oncology Closes $175M Series C …

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology revealed on Wednesday that it’s put together a $175 million Series C, aiming to fund clinical ... Channels. All News; In Focus; ... Alpha-9 Oncology CEO. …

endpts.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON, MA & VANCOUVER, BC – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

lifesciencesbc.ca

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully …

epicos.com

FAQs about Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed … Coupon?

Who is alpha-9 oncology?

BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Why did alpha-9 announce a $175 million Series C financing?

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Is alpha-9 a good radiopharmaceutical company?

“Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. “The Series C is an exciting, significant milestone for us and will greatly accelerate our growth. ...

What is alpha-9 pharmacology?

Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. For more information, please visit www.a9oncology.com. About Lightspeed Venture Partners ...

Why should you invest in a series C of alpha-9?

Furthermore, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. ...

What's new at Alpha 9?

"Alpha-9 is developing a differentiated portfolio that includes multiple radiopharmaceuticals with first-in-class and best-in-class potential," said Shelley Chu, head of Lightspeed Venture Partners' healthcare team. "We are impressed with the team's progress to date and are proud to support the advancement of these programs." ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension